Journal
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE
Volume 11, Issue 2, Pages 414-421Publisher
ELSEVIER
DOI: 10.1016/j.jaip.2022.10.037
Keywords
Penicillin allergy; Penicillin allergy delabeling; Clinical decision support; Electronic health records; Mobile telephone applications; Antimicrobial stewardship; Patient safety
Categories
Ask authors/readers for more resources
Allergy labels are common, often incorrect, and potentially harmful. Clinical decision support (CDS) tools integrated in electronic health records (EHR) and mobile apps can provide solutions for drug allergy management, including penicillin allergy delabeling (PADL). Improving the infrastructure and relevance of drug allergy alerts is important to reduce alert fatigue and facilitate appropriate antibiotic use.
Allergy labels are common, often incorrect, and potentially harmful. There are many opportunities for clinical decision support (CDS) tools integrated in the electronic health record (EHR) and mobile apps to address the challenges with drug allergy management, including penicillin allergy delabeling (PADL). Effective delabeling solutions must consider multidisciplinary clinical workflow and multistep processes, including documentation, assessment, plan (eg, allergy testing and referral), record update, drug allergy alert management, and allergy reconciliation over time. Developing a systematic infrastructure to manage allergies across the EHR is critical to improve the accuracy and completeness of a patient's allergy and avoid inadvertently relabeling. Improving the appropriateness and relevancy of drug allergy alerts is important to reduce alert fatigue. Using alerts to guide clinicians on appropriate antibiotic use may reduce unnecessary b-lactam avoidance. To date, EHR CDS tools have facilitated non-allergists to provide PADL at the point of care. A mobile app was shown to support PADL and provide specialist support and education. Future research is needed to standardize, integrate, and evaluate innovative CDS tools in the EHR to demonstrate patient safety and clinical utility and facilitate wider adoption.(c) 2022 American Academy of Allergy, Asthma & Immunology
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available